[1]JournaloftheChemicalSociety.PerkintransactionsI,1992,p.3129-3134
Title: A novel MDCKII in vitro model for assessing ABCG2-drug interactions and regulation of ABCG2 transport activity in the caprine mammary gland by environmental pollutants and pesticides.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20140401
Title: Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept.
Journal: Veterinary parasitology 20120210
Title: Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
Journal: Parasitology research 20111001
Title: Residual concentrations of the flukicidal compound triclabendazole in dairy cows' milk and cheese.
Journal: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20110401
Title: Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells.
Journal: Chemico-biological interactions 20100805
Title: Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
Journal: Parasitology research 20100501
Title: Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
Journal: BMC veterinary research 20100101
Title: Detoxifying and anti-oxidant enzymes of Fasciola gigantica worms under triclabendazole sulphoxide (TCBZ-SX): an in vitro study.
Journal: Journal of the Egyptian Society of Parasitology 20090401
Title: Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
Journal: Veterinary parasitology 20090205
Title: Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.
Journal: Veterinary research communications 20080101
Title: Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
Journal: The Journal of parasitology 20061201
Title: Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
Journal: The American journal of tropical medicine and hygiene 20060801
Title: Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep.
Journal: Journal of veterinary pharmacology and therapeutics 20060601
Title: Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics.
Journal: Experimental parasitology 20060501
Title: Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
Journal: Parasitology research 20041201
Title: The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
Journal: Parasitology research 20040201
Title: Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
Journal: Parasitology research 20020401
Title: Barrera B, et, al. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP. Antimicrob Agents Chemother. 2012 Jul;56(7):3535-43.
Title: Robinson MW, et, al. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol Res. 2004 Feb;92(3):205-10.
